AI assistant
Orchid Pharma Limited Major Shareholding Notification 2021
60526_rns_2021-04-16_48c6fc4c-1d5a-4f1f-80d9-aecf09378ab7.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
$DHANUKA$ Laboratories Ltd.
CIN No.: U24100DL1993PLC052285
Unit-I: 7th Km. Old Manesar Road, Village Mohammedpur, Gurgaon - 122004 Harvana, (INDIA) Phone: +91 124 4848900 Fax: +91 124 4848999 Email: [email protected] Website: www.dhanukalab.com Unit-II: Plot No. SP4-4, Industrial Area, Keshwana Raiput, Kotputli, Shahpura, Distt. Jaipur-303108 (Rajasthan) INDIA
April 05, 2021
| The Manager | The Manager |
|---|---|
| Listing Department | Listing Department |
| BSE Limited | National Stock Exchange of India Limited |
| Phiroze Jeejeebhoy Towers | Exchange Plaza, 5th Floor |
| Dalal Street, Mumbai- 400 001 | Plot No. C/1, G Block, Bandra Kurla Complex, |
| Scrip Code: 524372 | Bandra-East |
| Mumbai-400051 | |
| SYMBOL: ORCHPHARMA | |
Sub: Disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulation, 2011
Dear Sir/Madam
Pursuant to the provisions of Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, we the Promoters, members of the Promoter Group including Persons acting in concert of Orchid Pharma Limited hereby declare that we have not made any encumbrance of shares, directly or indirectly during the Financial Year ended March 31, 2021.
Kindly take the above disclosure on your records.
Thanking you
Yours sincerely
For Dhanuka Laboratories Limited
Manish Dhanuka Managing Director
Copy to: (1) Members of the Audit Committee-Orchid Pharma Limited (2) The Company Secretary-Orchid Pharma Limited
April 05, 2021
The Manager Listing Department BSE Limited Phiroze Jeejeebhov Towers Dalal Street, Mumbai- 400 001 Scrip Code: 524372
The Manager Listing Department National Stock Exchange of India Limited Exchange Plaza, 5th Floor Plot No. C/1, G Block, Bandra Kurla Complex, Bandra-East Mumbai-400 051 SYMBOL: ORCHPHARMA
Sub: Disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulation, 2011
Dear Sir/Madam
Pursuant to the provisions of Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, we the Promoters, the members of the Promoter Group including Persons Acting in Concert (PAC) of Orchid Pharma Limited hereby declare that we have not made any encumbrance of shares, directly or indirectly during the Financial Year ended March 31, 2021.
Kindly take the above disclosure on your records.
Thanking you
Yours sincerely
For and on behalf of Promoter, Promoter Group and PAC
Valhamil
MANISH DHANUKA PROMOTER
Copy to: (1) Members of the Audit Committee-Orchid Pharma Limited (2) The Company Secretary-Orchid Pharma Limited